Richard M. Jelinek, Director at Evolent Health, Inc. (EVH), bought 30,000 shares at $9.09 ($274K) on 2025-03-07, disclosed to the SEC on 2025-03-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.09 | 15,000 | $136K | 49.8% |
| 2 | $9.16 | 15,000 | $137K | 50.2% |
| Total | $9.13 avg | 30,000 | $274K | 100% |